B
BioNetrix Systems Corp
BioNetrix Taps Dell Managed Service Veteran To Lead Company’s New Authentication Service Provider Business
About BioNetrix Systems Corp
BioNetrix Systems Corp., now operating as BNX Systems, was established in 1997 by co-founders Peter Bianco, a former executive recruiter, and Karl Ware, who previously worked with the Central Intelligence Agency. The firm specializes in controlled-access management technology, addressing the need for interoperability between disparate biometric security systems.
The core of the company's offering is a proprietary sign-on technology that enables various authentication devices—such as smart cards, tokens, and a wide array of biometrics including fingerprint, iris, and facial scanners—to communicate seamlessly regardless of their underlying software. This creates a unified security framework for enterprise environments. The technology has found applications within the finance, healthcare, and government sectors.
Initially, the company's market strategy involved selling "StarterKits" for $2,500, which provided customers with BioNetrix software and a limited set of devices for voice, face, and fingerprint recognition. This approach secured early clients like DrugEmporium.com and the World Bank. In a significant strategic shift in 2000, John Ticer was appointed CEO to spearhead a push towards acquiring Fortune 500 accounts and guide the company towards a potential initial public offering or acquisition. Over its history, the company has successfully raised $9 million in funding to support its growth and technological development.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2010 | — | — | Undisclosed | — |
| SERIES B✓Equity / VC | Mar 2000 | $15M | $60M | The Carlyle Group · Columbia Capital · Steve Walker | — |
Growth signals
Latest recorded traffic for BioNetrix Systems Corp is 0 monthly website visits, down 100% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
The Carlyle Group
Columbia Capital
Steve Walker
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioNetrix Systems Corp on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioNetrix Systems Corp’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





